An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study

An Epidemiological Study of Acute Coronary Syndromes in The Greek Population

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01061086

Acronym

TARGET

Enrollment

418

Registered

2010-02-02

Start date

2010-01-31

Completion date

2011-02-28

Last updated

2011-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndromes

Keywords

Acute Coronary Syndromes, Epidemiology, Management of disease, Outcomes, Greece

Brief summary

This is a multicenter, 2-phase observational study of acute coronary syndromes (ACS) in Greece, designed to provide real world data on the risk factors of patients presenting to a hospital emergency department with an index event, as well as to depict the current management practices and outcomes of these clinical conditions in Greece.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of an ACS (STEMI, NSTEMI, UA). * Informed Consent

Exclusion criteria

* Involvement in the planning and conduct of the study (applies to both AstraZeneca staff and staff at the study sites). * Participation in other clinical study in period between the index event and 6- month follow-up assessment with the exception of registering in registries or surveys not influencing the management of the ACS.

Design outcomes

Primary

Measure	Time frame
To evaluate the proportion of patients who are on target for LDL-C according to the 2004-updated NCEP ATPIII guidelines as calculated within the first 24-hours of hospital admission for an ACS.	first visit - 1st day (cross-sectional part)
To estimate the proportion of patients enrolled in the cross-sectional part of the study that experiences a Major Adverse Cardiovascular Event (MACE) within a 6-month follow-up period.	follow up visit - 6th month (prospective part)

Secondary

Measure	Time frame
To estimate the proportion of patients admitted to the hospital with STEMI, NSTEMI and unstable angina.	first visit - 1st day (cross-sectional part)
To estimate the pain-to-door-time throughout different regions in Greece.	first visit - 1st day (cross-sectional part)
To estimate the time to first MACE and to estimate CV, non-CV and all cause mortality within the 6-month period following the index ACS event.	follow up visit - 6th month (prospective part)

Countries

Greece

Outcome results